In order to establish infections, picornaviruses are optimized to invade target cells, replicate large numbers of progeny virions, and spread these progeny to initiate new rounds of infection in neighboring cells. However, host organisms possess systemic, as well as cell-based, defense mechanisms to limit virus spread and to remove the virus at last. The innate cellbased responses to viral infections, which include the interferon (IFN) system and apoptosis of infected cells, are designed to act fast at the sites of infection. Induction of IFN synthesis in infected cells can curtail the spread of infection by inducing an antiviral state in neighboring cells, whereas induction of apoptosis can interrupt the infection cascade by entailing death of the infected cells without virus release. The inducer for IFN synthesis and in some cases also for apoptosis is double-stranded RNA (dsRNA) formed as a result of replication or convergent transcription of viral genomes (5, 6, 13, 18, 28, 34) . The effectiveness of both antiviral responses has led to many viruses developing specific mechanisms that antagonize the production or actions of IFNs (25; for reviews, see references 12 and 26) and prevent apoptosis (for a review, see reference 23).
In particular viruses that establish persistent infections have to cope with the cellular antiviral responses. Although hepatitis A virus (HAV), which belongs to the picornavirus family, never causes chronic infection with viral persistence in the host organism in vivo, infection in cultured cells results in a persistent noncytopathic infection (7, 11, 31) . At the cellular level this seems also to be true for the situation in vivo, in which massive hepatocyte destruction is mediated mainly by the action of cytotoxic T lymphocytes (32) . These characteristics of HAV infection imply that, without involvement of the cellular immune system, HAV replication results in persistent infections and that therefore HAV has developed mechanisms to prevent or reduce cellular antiviral responses.
Indeed, various investigations demonstrated that HAV infection did not result in measurable human alpha IFN (IFN-␣) levels in lymphocytes or IFN-␤ levels in fibroblasts (30) . Furthermore, fibroblasts infected persistently with HAV did not interfere with the infection by other viruses (30, 31) . This finding that HAV replication obviously does not induce IFN-␣/␤ synthesis is supported by experiments that showed that even small amounts of exogenous IFN-␣/␤ are able to eliminate persistent HAV infections in human fibroblasts (29, 31) . In contrast to these experimental results, which give evidence that HAV cannot induce IFN-␣/␤ expression, data were presented that demonstrate that IFN-␥ is produced after HAV stimulation by HAV-specific HLA-dependent cytotoxic T lymphocytes in vitro and may play a role in the elimination of HAV infection in humans (19) . The principal difference between the induction of these IFNs is that IFN-␣/␤ is produced rapidly in direct response to viral replication by infected cells, whereas IFN-␥ is synthesized in response to the recognition of infected cells by activated T lymphocytes later in the course of infection (12). Although it has been known for many years that HAV infection does not result in IFN-␣/␤ synthesis in vitro, the mechanism by which HAV interferes with the expression of IFNs is not known, and therefore the role of IFN-␣/␤ in the elimination of HAV during an acute infection is still uncertain.
The intention of our investigation was to find out at which level HAV interferes with IFN-␤ synthesis. We found that cells infected with HAV do not transcribe IFN RNA and do not synthesize IFN in response to the synthetic dsRNA poly(IC), which is an inducer of IFN synthesis. These cells also resist apoptosis caused by dsRNA molecules.
MATERIALS AND METHODS

Cells.
Fetal rhesus monkey kidney cells (FRhK-4), human embryonic lung fibroblasts (MRC-5), and human amnionic cells (WISH) were maintained as continuous cultures in Dulbecco modified Eagle medium (DMEM) supplemented with 1 or 3% (MRC-5) fetal calf serum (FCS). In order to split the cells at a ratio of 1:2 (MRC-5) and 1:5 (FRhK-4 and WISH), they were detached from the tissue culture plate with trypsin supplemented with 0.2 g of sodium-EDTA/ liter and cultivated with DMEM-10% FCS as the growth medium.
FRhK-4/(Ϫ110IFN-␤)-CAT cells were obtained by calcium phosphate transfection with FRhK-4 cells, which were cultivated on 6-cm dishes, and 5 g of the (Ϫ110IFN-␤)-CAT reporter plasmid, which was kindly provided by T. Maniatis (9) . To establish stable cell lines containing the reporter plasmid the cells were cotransfected with 2 g of pSV2neo (Clontech) and cultured with selection medium containing 600 g of G418 per ml. To test induction of the chloramphenicol acetyltransferase (CAT) reporter gene, cell clones were transfected with 20 g of poly(IC)/ml by using DEAE-dextran and CAT expression was analyzed by enzyme-linked immunosorbent assay (ELISA) 16 h after induction.
Viruses. HAV/7 (noncytopathogenic) (3) and HAV cyt/HB1.1 (cytopathogenic) (1), which are variants of strain HM175, were propagated in FRhK-4 cells as described previously (1) . HAV strain GBM (noncytopathogenic) (10) was propagated in MRC-5 cells at 37°C. Vesicular stomatitis virus (VSV) strain Indiana was passaged on FRhK-4 cells. HAV was prepared by triple freeze-thaw cycles, with VSV in one step, and then the cellular debris was removed.
The 50% tissue culture infective dose (TCID 50 ) titers of HAV were determined by indirect immunofluorescence with the monoclonal mouse anti-HAV immunoglobulin G (IgG) antibody 7E7 (Mediagnost, Reutlingen, Germany), and the titer of VSV was determined by a plaque assay. The titers were calculated by the Kärber method (14) .
In order to neutralize HAV, HAV-anti-HAV IgG immunocomplexes were prepared by incubating HAV (10 5 to 10 6 TCID 50 /ml) with 20 g of anti-HAV IgG antibody 7E7 per ml for 2 h at room temperature in DMEM (8) . Since these antibodies neutralize HAV upon infection of FRhK-4 cells, complex formation was assayed by infection inhibition on FRhK-4 cells, which was determined by titration and compared to that obtained with HAV alone in amounts equal to those in the samples with antibodies.
Detection of IFN activity and IFN mRNA. IFN activity in supernatants of cells was measured by determination of the reduction of VSV growth in WISH cells (plaque reduction assay) (17) . Cells cultivated in 96-well plates were incubated with serial dilutions of cell culture supernatants for 20 h at 37°C. After two washes, the cells were incubated with 80 PFU of VSV/well for 1 h at 37°C. After removal of the inoculum, DMEM supplemented with 1% methylcellulose and 2% FCS was added, and the cells were incubated for 2 days at 37°C, fixed with 4% formalin for 15 min at room temperature, and stained with crystal violet (0.4%) for 10 min at room temperature. IFN titers are expressed in terms of a reference standard provided by the NIH (Reference Reagent Repository, Gaithersburg, Md.). One unit of IFN is defined as the dilution that results in 50% plaque reduction. Incubation of WISH cells with IFN in the presence of HAV demonstrated that HAV in cell culture supernatants does not influence the plaque reduction assay.
IFN mRNA was detected by reverse transcription-PCR (RT-PCR) by using total cellular RNA, which was prepared by acid guanidinium thiocyanate-phenolchloroform extraction (2) and treated with DNase I (5 U/100 l) for 30 min at 37°C. RT was performed for 45 min at 42°C in the presence of antisense primers and 2 U of reverse transcriptase in a total volume of 20 l. Then, 5 l of the RT product was used in the following PCR. The primers used were specific for IFN-␣ and IFN-␤ (27), respectively, and primers specific for ␤-actin were used as loading control in a separate reaction. After 2 min at 94°C, the reaction parameters used for 30 cycles were 1 min at 94°C, 2 min at 60°C, and 3 min at 72°C. The sequences of the primers used were IFN-␣ sense [5Ј-GGAAGCTT(CT)CTCCT G(CT)(CT)TGA(AT)GGACAGA-3Ј], IFN-␣ antisense [5Ј-GGGGATCCTCT GACAACCTCCCA(AGCT)GCACA-3Ј], IFN-␤ sense (5Ј-ACCAACAAGTGT CTCCTCCA-3Ј; nucleotides 361 to 380), IFN-␤ antisense (5Ј-GAGGTAACCT GTAAGTCTGT-3Ј; nucleotides 893 to 912), ␤-actin sense (5Ј-AGAAGAGCT ACGAGCTGCCTGACG-3Ј; nucleotides 751 to 774), and ␤-actin antisense (3Ј-CGTCATACTCCTGCTTGCTGATCC-3Ј; nucleotides 1107 to 1131).
Induction of IFN synthesis and apoptosis by dsRNA. IFN synthesis and apoptosis were induced by incubating cells cultivated in 6-cm dishes and washed once with DMEM with 2 ml of DMEM supplemented with 20 g of polyinosinicpoly(C) [poly(IC)]/ml in the presence of 100 g of DEAE-dextran/ml for 2 h at 37°C. After one wash with Hank's balanced salt solution, the cells were incubated for 12 to 16 h at 37°C, and samples were prepared to analyze IFN-␤ activity, IFN-␤ mRNA, and apoptosis, respectively.
Detection of apoptosis. Apoptosis was analyzed by DNA fragmentation and quantified by flow cytometry (1) . In order to investigate DNA fragmentation, 2 ϫ 10 6 cells were washed twice with phosphate-buffered saline (PBS) and lysed in 400 l of lysis buffer (10 mM Tris [pH 7.5], 0.5% Triton X-100) for 30 min on ice. Nuclei were removed, and the supernatants were extracted with phenol-chloroform. After precipitation, the samples were treated with RNase A (final concentration, 1 g/ml) and analyzed electrophoretically.
For flow cytometric analysis, the cells were treated with trypsin, washed twice with PBS, and fixed with 70% ethanol in PBS at 4°C overnight. For nuclear staining, the cell were incubated with PBS supplemented with 50 g of propidium iodide, 100 U of RNase A, and 0.1% glucose per ml for 30 min at room temperature. After transfer of the cells to 1 ml of isotonic buffer (Isoton II; Coulter), the DNA fluorescence profiles were recorded by using the EPICS XL flow cytometer (Coulter). Apoptotic nuclei were identified as a subdiploid peak with a DNA content of Ͻ2 N.
CAT reporter gene assay. At 16 h postinduction with 20 g of poly(IC) and 100 g of DEAE-dextran per ml, FRhK-4/(Ϫ110IFN-␤)-CAT-cell extracts were prepared by triple freeze-thaw cycles, and expression of the CAT reporter gene was analyzed by the CAT-ELISA (Roche) as described by the manufacturer, with normalization of the protein concentrations in the cell extracts. Detection of HAV-specific dsRNA. HAV dsRNA was detected by the hybrid detection assay (HDA) (24) . In order to prepare dsRNA without contamination by single-stranded RNA, total cellular RNA, which was prepared by acid guanidinium thiocyanate-phenol-chloroform extraction, was treated with RNase A (final concentration, 35 g/ml) in the presence of 0.3 M NaCl for 45 min at 15°C. After precipitation, the dsRNA extracts were hybridized with a biotinylated single-stranded DNA probe specific for HAV minus-strand RNA. The RNA-DNA hybrids were captured onto streptavidin-coated microwells, incubated with an anti-hybrid antibody conjugated to alkaline phosphatase (Digene Corporation, Gaithersburg, Md.), and detected with a chemiluminescent substrate by use of a luminometer.
RESULTS
HAV infection does not induce IFN-␤ synthesis.
Former investigations demonstrated that human fibroblasts infected with HAV do not secrete IFN-␤ (31). This implies that HAV replication in these cells does not result in IFN production.
In order to prove that the inability to respond to HAV infection with IFN synthesis is not an attribute of specific cell lines and/or HAV variants, the monkey kidney cell line FRhK-4, which is a standard cell line for HAV propagation, and the human lung fibroblast cells MRC-5 were infected at an multiplicity of infection (MOI) of 1 to 4 with HAV strain HM175 (HAV/7) and HAV strain GBM (HAV-GBM), respectively. IFN expression was analyzed by plaque reduction activity of the supernatants by using VSV as challenge virus as well as by IFN mRNA detection by RT-PCR at different times after infection. This allows the differentiation whether IFN synthesis is influenced at the level of transcription or posttranscriptionally. Infection of the cells was confirmed by indirect immunofluorescence.
Up to 72 h postinfection (p.i.), at which time all cells were infected, no IFN activity could be detected at any time in the cell culture supernatants with both cell lines and virus strains used (data not shown). The same results were obtained with cells infected with cell lysates of noninfected cells as negative controls (data not shown). Also, no IFN mRNA was detectable in the cell extracts at the times indicated, as shown for FRhK-4 cells infected with HAV/7 ( These results confirm earlier suggestions that HAV infection does not result in IFN-␤ production in cultured cells (30) and show that the absent IFN-␤ response on HAV replication is based on the nonappearance of IFN mRNA transcription.
HAV inhibits dsRNA-induced expression of IFN-␤. Viruses vary considerably in their ability to induce IFN synthesis. This may reflect the fact that they are poor inducers of IFN or that they antagonize the induction of IFN transcription.
In order to examine whether HAV, which replicates exceptionally slowly in cultured cells, is a less potent IFN inducer or does inhibit IFN induction by dsRNA, poly(IC) was transfected into FRhK-4 cells infected with HAV/7 with an MOI of 0.1 and MRC-5 cells infected with HAV-GBM with an MOI of 0.1 at different times after inoculation. Transfection by the DEAE-dextran method does exclude the possibility that infection by HAV merely inhibits the uptake of poly(IC). Analysis by plaque reduction assay by using VSV showed that poly(IC) at 20 g/ml in the presence of DEAE-dextran strongly induced the secretion of IFN into the supernatants of FRhK-4, as well as of MRC-5 cells, which was completely inhibited in the HAV-infected cells 4 days p.i. (Fig. 2A) . Neither in HAVinfected nor in noninfected cells transfected without poly(IC) did IFN synthesis occur significantly ( Fig. 2A) . Compared to noninfected cells, induction of IFN synthesis immediately after HAV inoculation (day 0) and at 1 and 4 days p.i. by poly(IC) revealed that IFN activity in the supernatants is already strongly reduced by 80% in FRhK-4 cells and is reduced by 63.4% in MRC-5 cells by 1 day p.i. and is nearly absent by 4 days p.i. under these experimental conditions (Fig. 2B) . This result strongly suggests that dsRNA-induced IFN synthesis is inhibited by the replicating HAV. This is supported by the result that under the same experimental settings, but with HAV neutralized by anti-HAV IgG, only a moderate reduction of IFN activity after poly(IC) induction was detected compared to noninfected cells (Fig. 2B) , which presumably resulted from HAV not associated with IgG antibodies.
In order to investigate whether the inhibition of IFN secretion by HAV occurs at the level of IFN-␤ transcription, the expression of IFN-␤ mRNA was analyzed by RT-PCR. FRhK-4 and MRC-5 cells infected with HAV/7 (MOI of 3) and HAV-GBM (MOI of 1), respectively, were transfected with 20 g of poly(IC)/ml by DEAE-dextran at days 1, 4, and 6 p.i., and cellular RNA was extracted 12 to 16 h after transfection. In comparison to noninfected cells, which were also treated with poly(IC) and in which strong signals for IFN-␤ mRNA were detected at the times analyzed, only weak signals indicating IFN-␤ mRNA were detectable at day 1 p.i. and no IFN-␤ mRNA at all was detectable 4 and 6 days after HAV infection (Fig. 3 ).
These results demonstrate that HAV inhibits dsRNA-induced IFN-␤ gene expression and strongly imply that the inhibition of IFN-␤ synthesis occurs during the events leading to transcription of IFN-␤ mRNA.
HAV does not induce the IFN-␤ enhancer and inhibits the induction of IFN-␤ mRNA transcription by dsRNA. In order to prove that HAV inhibits the transcription of IFN-␤ mRNA, FRhK-4 cells were stably transfected with CAT as a reporter gene linked to the intact IFN-␤ enhancer-promoter by calcium phosphate transfection of the (Ϫ110IFN-␤)-CAT plasmid (9, 15) .
After transfection of these cells with 20 g of poly(IC)/ml by DEAE-dextran, proteins were extracted 16 h after transfection and 100 g of protein were analyzed for expression of the CAT reporter gene by the CAT-ELISA. In these experiments high levels of CAT were detected (Fig. 4) , which shows that the IFN-␤ enhancer was induced strongly by dsRNA. Transfection without poly(IC), which was used as a control, did not result in CAT expression (Fig. 4) .
In order to examine whether HAV replication does not induce the IFN-␤ enhancer, FRhK-4/(Ϫ110IFN-␤)-CAT cells were infected with HAV/7 with an MOI of 4 and analyzed for CAT expression 2 days p.i. As shown in Fig. 4 , no CAT was detectable, which demonstrates that HAV does not induce the IFN-␤ enhancer and therefore IFN-␤ mRNA transcription.
Moreover, induction of CAT expression by poly(IC) in FRhK-4/(Ϫ110IFN-␤)-CAT cells was completely inhibited in cells, which were infected with HAV/7 at an MOI of 4 1 day prior induction (Fig. 4) . Thus, HAV does inhibit activation of the IFN-␤ enhancer in response to dsRNA. HAV inhibits dsRNA-induced apoptosis. Transfection of 20 g of poly(IC)/ml with DEAE-dextran into FRhK-4 cells resulted not only in induction of IFN-␤ production but also in the induction of apoptotic cell death, which was analyzed by DNA fragmentation 12 h after transfection (Fig. 5) . However, in FRhK-4 cells, which were infected persistently with HAV/7, which does not induce DNA fragmentation on its own (1), no DNA fragmentation occurred after treatment with poly(IC) (Fig. 5) . Therefore, it was supposed that HAV/7 inhibits dsRNA-induced apoptosis. In order to obtain more quantitative data with regard to the inhibitory effect of HAV on dsRNA-induced apoptosis, we analyzed by flow cytometry the DNA contents of FRhK-4 cells that either were not infected or were infected with HAV/7 after treatment with poly(IC). For this purpose, cells were infected with an MOI of 0.1. Immediately after inoculation with HAV (day 0) and at days 1 and 4 p.i., cells were transfected with 20 g of poly(IC)/ml by DEAE-dextran and after an incubation time of 12 h, cells were prepared for fluorescence-activated cell sorting (FACS) analysis. Apoptotic nuclei were identified as a subdiploid peak (DNA content, Ͻ2 N). To demonstrate the specificity of the viral effect, HAV/7 neutralized by anti-HAV IgG and cell lysates of noninfected cells supplemented with or without anti-HAV IgG in amounts equal to those used for neutralization of HAV, respectively, were used as controls. The results obtained are shown in Table 1 . For cells infected with HAV/anti-HAV IgG complexes, the percentage of apoptotic cells was identical to that inoculated with the cell lysate and the lysates supplemented with IgG, with values between 7 and 12.5 after treatment with poly(IC) at days 0, 1, and 4 p.i. However, after infection with HAV/7, the proportion of apoptotic cells after poly(IC) treatment decreased from 12.5% at day 0 p.i., which correponds to the value obtained with noninfected cells, to 3.4% at day 1 p.i. and 2.1% at day 4 p.i., which almost corresponds to the mean value of 1.3% apoptotic cells for FRhK-4 cells transfected with DEAEdextran without poly(IC).
These results demonstrate that HAV/7 inhibits apoptotic cell death induced by poly(IC) in FRhK-4 cells. In contrast to this, HAV is not able to prevent apoptosis induced by actinomycin D and cycloheximide, which are inhibitors of macromolecular synthesis, on which we reported previously (1) .
A cytopathogenic variant of HAV also does not induce IFN-␤ mRNA transcription but is deficient in inhibiting dsRNA-induced IFN-␤ mRNA transcription and apoptosis. Cytopathogenic HAV variants replicate much faster and generate significantly more viral products than noncytopathogenic HAV. This is reflected by exceptionally high viral titers and In order to investigate the influence of HAV cyt/HB1.1 on dsRNA-induced synthesis of IFN-␤, FRhK-4 cells infected with an MOI of 4 with HAV/7 and HAV cyt/HB1.1 , respectively, were treated with poly(IC), and at 2 days p.i., IFN-␤ mRNA was analyzed by RT-PCR and IFN activity in cell supernatants was tested by the plaque reduction assay. Under these conditions, at which virtually every cell is infected, no IFN was detectable in cells infected with HAV/7, whereas in cells which were infected with HAV cyt/HB1.1 , IFN as well as IFN-␤ mRNA could be detected in low amounts (data not shown). A mixed population of HAV cyt/HB1.1 and HAV/7 can be excluded, as HAV cyt/HB1.1 was clonally selected for three times.
Thereupon, in order to obtain more quantitative data, we examined the consequence of HAV cyt/HB1.1 replication on in- a Cells were inoculated for 2 h at 34°C with HAV/7-anti-HAV IgG complexes or HAV/7 in amounts equivalent to those in the complex inoculum (MOI 0.1), transfected with poly(IC) by DEAE-dextran at different times p.i. and after an incubation time of 12 h prepared for FACS analysis. Shown are the data of an experiment representative for a series of three.
b As controls, cell lysates of noninfected cells supplemented with (ϩ) or without (Ϫ) anti-HAV IgG in amounts equal to those used for neutralization of HAV were used as the inoculum. In addition, mock-infected cells were transfected with DEAE-dextran without (Ϫ) poly(IC).
c Day p.i. at which poly(IC) treatment (20 g/ml) was begun. Table 2 demonstrated that HAV cyt/HB1.1 also inhibits activation of the IFN-␤ enhancer in response to dsRNA but to a notably lesser extent than HAV/7, which replicates significantly more slowly than HAV cyt/HB1.1 . Experiments with preparations of empty HAV capsids (22) , as well as with inactivated vaccine virus in amounts equivalent and higher than in the infectious virus preparation, revealed that replication is necessary for HAV to inhibit the effect of poly(IC), since no inhibitory effect on dsRNA-induced CAT expression was observed (data not shown). It is therefore remarkable that the attenuated inhibition on dsRNA-induced CAT expression by HAV cyt occurred in the presence of a vast viral replication. We also examined whether HAV cyt/HB1.1 affects dsRNA-induced apoptosis. FRhK-4 cells were infected with HAV cyt/HB1.1 with an MOI of 4, and apoptosis was induced by transfection with 20 g of poly(IC)/ml at 24 h p.i. Apoptotic nuclei were determined by flow cytometry 12 h after induction. In order to compare the cytopathogenic variant with the noncytopathogenic variant, HAV/7-infected cells were treated in the same way. In noninfected cells, which were used as controls, poly(IC) induction resulted in 5.3% apoptotic cells (Fig. 6 ). This proportion was reduced to 2.6% in cells infected with HAV cyt/HB1.1 . At this time p.i., no apoptotic cell death caused by HAV cyt/HB1.1 was detectable. An even stronger reduction to a value of 1.7% was obtained with HAV/7. Although HAV cyt/HB1.1 was able to reduce dsRNA-induced apoptosis, the proportion of apoptotic cells increased with advancing incubation periods, reaching more than 20% at day 14 p.i. without poly(IC) induction (Fig.  6) .
These results show that HAV cyt/HB1.1 inhibits apoptosis, which is induced by dsRNA, but not as effectively as the noncytopathogenic HAV/7.
Appearance and relative amounts of viral dsRNA during infection with noncytopathogenic and cytopathogenic HAV variants. As the competence to inhibit cellular antiviral mechanisms, which are induced by dsRNA, is different in the case of cytopathogenic and noncytopathogenic HAV, we recorded the relative amounts of viral dsRNA during infection with both variants in the course of 72 h. FRhK-4 cells were infected with HAV cyt/HB1.1 and HAV/7, respectively, with an MOI of 1. At various times cellular RNA was extracted and treated with RNase A under conditions specific for the degradation of single-stranded RNA, and the remaining dsRNA was analyzed for HAV-specific dsRNA by HDA. We detected HAV dsRNA for the first time 40 h after inoculation with HAV cyt/HB1.1 with increasing amounts till 48 h p.i., which declined till 72 h p.i. (Table 3 ). In contrast, HAV/7 dsRNA could be detected for the first time 72 h p.i. These results, together with the finding that HAV cyt/HB1.1 is deficient in its inhibitory effect on dsRNAinduced apoptosis, might imply that HAV cyt dsRNA is involved in induction of apoptotic cell death after infection with cytopathogenic HAV variants. This is supported by the observation that the appearance and amount of dsRNA correlate with morphological changes of the cells infected with HAV cyt/HB1.1 that are indicative of apoptosis, whereas with HAV/7 even after the appearance of small quantities of viral dsRNA, no cytopathic effect (CPE) could be detected (Table 3) . However, IFN-␤ synthesis is induced neither by HAV cyt nor by noncytopathogenic HAV.
Noncytopathogenic HAV interferes with HAV cyt . In further experiments we examined whether noncytopathogenic HAV influences the apoptotic reaction induced by HAV cyt . We infected FRhK-4 cells, which were persistently infected with HAV/7 with a titer of 10 6 TCID 50 /10 6 cells, with HAV cyt/HB1.1 at an MOI of 0.07. Analysis of the fraction of apoptotic cells by flow cytometry demonstrated that no apoptosis was induced in the course of 14 days p.i., whereas in cells noninfected with HAV/7 apoptosis occurred between days 7 and 10 after infection with HAV cyt/HB1.1 , reaching more than 20% apoptotic cells by day 14 p.i. (Fig. 7A) .
The records of the replication kinetics of HAV cyt/HB1.1 revealed that, under these conditions, HAV cyt/HB1.1 replicated in FRhK-4 cells, which were persistently infected with HAV/7, considerably more slowly than in cells noninfected with HAV/7 (Fig. 7B) . From day 5 p.i. onward the TCID 50 titers of HAV cyt/HB1.1 were reduced significantly in the presence of HAV/7, reaching 1.6 ϫ 10 6 TCID 50 /10 6 cells compared to 2.3 ϫ 10 7 TCID 50 /10 6 cells in cells noninfected with HAV/7 (Fig. 7B) . These titers were assessed by the morphological characteristics of apoptotic cells (1) . This is possible because simultaneous inoculation of FRhK-4 cells with HAV cyt/HB1.1 and HAV/7 does not influence the replication of HAV cyt/HB1.1 , as well as the apoptotic reaction induced by this variant (data not shown). It could also be demonstrated that the titers determined for HAV cyt/HB1.1 by CPE and by immunofluorescence are identical (data not shown).
These results show that, at a later stage of infection, HAV/7 is equipped with functions to reduce the replication of HAV cyt/HB1.1 and most likely its own also. Reduction of replication means less HAV dsRNA molecules and thus possibly prevention of the induction of apoptosis in the infected cells. The mechanisms involved in the control of the viral replication are not known.
The total TCID 50 titer in cells infected with both HAV variants was 1.1 ϫ 10 7 /10 6 cells 14 days p.i. As the indication for an apoptotic reaction after infection with HAV cyt/HB1.1 correlates with a TCID 50 titer of above 10 7 /10 6 cells (data not shown), it is also possible that at this time HAV/7 directly (4) 142 (12) 83 1.5 ϫ 10 7 (0.3) HAV cyt/HB1.1 (10) 68 (9) 92 ND a Mock-and HAV-infected cells were transfected with 20 g of poly(IC)/ml by DEAE-dextran 24 h p.i. and 16 h after induction, CAT expression was analyzed, and the TCID 50 titer was determined. The data are means obtained from two separate experiments, including two replicates.
b The standard deviation is shown in parentheses. c ND, not determined.
inhibited the induction of apoptosis, as described for induction of apoptosis by poly(IC).
DISCUSSION
We investigated the consequences of HAV infections on the induction of IFN-␣/␤ synthesis and apoptosis. These two reactions, which can be induced by dsRNA, are components of the cell-based antiviral mechanisms, which obviously are not effective against HAV infections in cultured cells, as HAV normally establishes persistent infections in cell culture (31) . In former experiments no IFN-␤ could be detected after infection of human fibroblasts with HAV-GBM, and no interference with other viruses occurred (30, 31) . This suggests that no endogenous IFN-␤ was produced and is supported by the fact that already small amounts of exogenous IFN-␤ could erase the infection (29, 31) . Therefore, HAV seems unable to inhibit IFN-␤-mediated gene expression and antiviral activities but seems able to influence IFN-␤ synthesis.
Using different strains of HAV and cell lines originating from various species and able to respond to induction with the production of IFN-␤, we show that HAV infections in general do not result in transcription of IFN-␤ mRNA. Taking advantage of the CAT gene as reporter, we could prove that the transcriptional induction of IFN-␤ by dsRNA is inhibited by the replicating HAV by influencing the formation of the transcription complex, the enhanceosome (20) .
Furthermore, we demonstrate that HAV also inhibits HAV cyt/HB1.1 , which is an exceptionally fast-replicating, apoptosis-inducing cytopathogenic FRhK-4 cell culture variant, also does not initiate IFN-␤ transcription, although this virus impairs less dsRNA-triggered IFN-␤ transcription than noncytopathogenic HAV. Despite the fact that HAV cyt/HB1.1 additionally produces more dsRNA than noncytopathogenic HAV, the attenuated repression on transcriptional activation of IFN-␤ seems sufficient to prevent IFN-␤ synthesis.
This might be different for the induction of apoptosis, because HAV cyt/HB1.1 is also deficient in inhibiting dsRNAinduced apoptosis. The mechanism by which HAV cyt/HB1.1 causes apoptosis is not known. Previously, we reported that HAV cyt/HB1.1 might interfere with the cellular control of apoptosis-promoting and apoptosis-preventing functions by competing with the cellular synthesis of macromolecules, because HAV is not equipped with antiapoptotic functions in the case of restrained macromolecular synthesis (1) . Based on the finding that the inhibitory effect on dsRNA-induced apoptosis is restricted in HAV cyt/HB1.1 infected cells, the higher amount of viral dsRNA molecules might contribute to the induction of the apoptotic cascade.
Besides this speculation, the attenuation of HAV cyt/HB1.1 in its ability to interfere with both dsRNA-induced IFN-␤ synthesis and apoptosis supports the suggestion that the two reactions are connected by common factors. The reduced ability of HAV cyt/HB1.1 to interfere with these cellular antiviral responses might be caused by mutational changes, which oc- curred during adaptation of the virus to better growth in FRhK-4 cells, and might refer to viral proteins, which interact with the signaling pathways leading to IFN-␤ synthesis and apoptosis. Recently, it was demonstrated that the IFN regulatory factor 3 (IRF3), together with the transcriptional coactivators CREB-binding protein (CBP) and p300, is involved in the induction of apoptosis caused by infection with Newcastle disease virus or stimulation with dsRNA independent from IFN (33). Since these transcription factors are also involved in the transcriptional activation of IFN-␤ (20) and since FRhK-4 cells are deficient in an IFN response, so that apoptosis induced by dsRNA or HAV cyt is independent of the action of IFN (unpublished results), it may be that HAV might interact with IRF3 and/or CBP/p300 to inhibit dsRNA-induced IFN-␤ synthesis and apoptosis. Since the attenuated competence to inhibit cellular antiviral responses seems to correlate with the degree of the adaptation of HAV to growth in cell culture, it can be assumed that wild-type HAV is equipped with a significant ability to inhibit these antiviral actions and that this attribute may play an important role for the pathogenesis during infections in vivo. The results support older suggestions that IFN-␣/␤ is not involved in the elimination of HAV under natural conditions (30) .
The ability of HAV to modulate dsRNA-induced IFN-␤ expression and apoptosis may assist or even allow the virus to establish an infection in vivo and in cell culture. After entry into host cells, HAV replicates exceptionally slowly. However, this may not ensure that activation of cellular dsRNA-induced antiviral responses such as IFN-␤ production is prevented. Therefore, the ability to repress dsRNA-induced transcriptional activation of IFN-␤ may guarantee that no antiviral activities by IFN-stimulated proteins are induced in the already infected cell as well as in surrounding noninfected cells. This would allow HAV to produce sufficient progeny virus to spread to neighboring cells and to establish new rounds of infections there. In order to prevent apoptotic cell death which might be caused by accumulating viral dsRNA, HAV is able to repress dsRNA-induced apoptosis by a mechanism, which is possibly based on the same mechanism as that responsible for the inhibition of IFN-␤ expression. Therefore, the usage of these anti-antiviral properties of HAV, by which already existing sites of virus production can be preserved and new sites of virus production can be initiated, may be the basic strategy to allow this slowly growing virus to establish infections and may be the presupposition for the persistent character of HAV infections.
The inhibition of dsRNA-induced cellular defense principles allows HAV to evade detection by the infected cells and may save time to establish infection. However, the anti-antiviral abilities of HAV may not be sufficient to completely inhibit the cellular defense principles at a later stage of infection when the cellular viral load is high and to allow HAV to establish a persistent infection. At least this seems to be true for the induction of apoptosis. As demonstrated with cytopathogenic variants, apoptosis can be triggered depending on the cellular viral load and possibly on the velocity of the viral replication by a mechanism which may be dependent on dsRNA. Previous studies suggested that the replication of noncytopathogenic HAV is downregulated at a later stage of infection (4, 21) , but elements in HAV RNA and factors which are involved in the regulation of viral RNA replication could not be positively defined until now (16, 21) . Our results also indicate that noncytopathogenic HAV is equipped with functions that result in a reduction of the viral replication at later times in the replication cycle and which ensure that viral dsRNA does not accumulate to amounts required to overcome the inhibitory functions of HAV on dsRNA-induced cellular defense mechanisms. This would result in the moderate replication allowing HAV to completely inhibit the cellular antiviral mechanisms and thus guarantee the persistent state of the infection. In addition, HAV seems to be able to make both functions, the inhibition of the dsRNA-induced cellular defense mechanisms and the downregulation of viral replication, dominantly available to HAV cyt in trans.
In summary, the results presented here show three new qualities of HAV, by which the virus interacts with host cells to establish persistent infections. (i) HAV inhibits dsRNA-induced IFN expression. (ii) HAV inhibits dsRNA-induced apoptosis. (iii) HAV is able to downregulate its own replication in cis, as well as that of cytopathogenic variants in trans. Further investigations with specific elements of the promoter-enhancer for IFN-␤ are required to dissect the mechanism by which HAV interferes with the transcription of IFN-␤ mRNA. It also remains to be shown by which mechanisms HAV interferes with apoptosis and by which further mechanisms HAV is able to establish persistent infections.
